Malecare, Author at malecare.org

Disease and Host Characteristics as Predictors of Time to First Bone Metastasis and Death in Men with Castration Resistant Nonmetastatic Prostate Cancer

Researchers at the Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts performed an evaluation of the natural history of castration-resistant non-metastatic prostate cancer. For their analysis, the researchers used data from 331 subjects in a placebo group of a randomized controlled trial to evaluate the relations of disease and host characteristics with time [...]

By Malecare|2017-10-19T10:53:23-04:00December 27th, 2010|Advanced Prostate Cancer, General Information, Metastases, Research, Uncategorized, Understanding APC|0 Comments

I BELIEVE…

That most people want to be happy but just don't know how. In many ways it's a life-long journey. But you have to want to take the journey and know what it looks like when you arrive at certain milestones along the way. That's the hard part. Being a jerk is beyond easy. Sure it [...]

By Malecare|2017-10-19T10:53:23-04:00December 24th, 2010|THE COACH, THE HOLIDAYS, THINGS I WISH MY DAD TOLD/TAUGHT ME|0 Comments

Projecting the Years of Potential Life Lost from Advanced Prostate Cancer in the U.S. (2004-2050)

This study estimated and projected the number of years of potential life lost (YPLL) among men who die of prostate cancer(advanced prostate cancer) in the United States from 2004 through 2050 and compare the projections by race/ethnicity and age, accounting for demographic changes and population growth. The researchers applied the life expectancy method to estimate [...]

By Malecare|2017-10-19T10:53:23-04:00December 23rd, 2010|Advanced Prostate Cancer, Advocacy, General Information, Politics of Cancer, Research, Uncategorized, Understanding APC|0 Comments

An Update on the FDA & EMA Submissions for Abiraterone for the Treatment of Metastatic Advanced Prostate Cancer

Applications for the approval of Abiraterone Acetate (Abiraterone) have been submitted to both the U.S. Food and Drug Administration (FDA) and to the European Medicines Agency (EMA). The applications are for the approval of Abiraterone with prednisone for the treatment of metastatic advanced prostate cancer in men who have received prior chemotherapy containing a taxane. [...]

By Malecare|2010-12-21T10:51:08-05:00December 21st, 2010|abiraterone acetate, Advanced Prostate Cancer, Drugs & Treatments, FDA, On The Horizon, Uncategorized|5 Comments

Stage IV Prostate Cancer Incidence Down, Survival Up, But More Younger Men Make up an Increased Proportion of the Diagnosed

According to a study funded by Amgen Inc., the incidence of stage IV prostate cancer has significantly declined and survival has improved, but the scary side of the equation is that younger men represent an increasing proportion of those diagnosed. The study was published in the June issue of Urology. […]

By Malecare|2017-10-19T10:53:24-04:00December 20th, 2010|Advanced Prostate Cancer, General Information, Politics of Cancer, Uncategorized, Understanding APC|1 Comment

ONE PERSON’S EXPERIENCE WITH PROVENGE

Malecare has an on-line support group for men with advanced prostate cancer; their loved ones and caretakers. Today, there was a post on the support group where one of the participants shared their recent experience with Provenge, including some very specific recommendations for anyone else thinking of having the treatment. You can join us by [...]

By Malecare|2021-02-17T10:21:06-05:00December 16th, 2010|Advanced Prostate Cancer, Drugs & Treatments, How We Live, Personal Experiences, Provenge, Uncategorized, Understanding APC, vaccines|44 Comments

Zoledronic Acid Shows Improved Clinical Outcomes When Administered Prior to Bone Pain in Men with Advanced Prostate Cancer

According to the FDA approval label, zoledronic acid (Zometa) should be administered to men with advanced prostate cancer once they have failed one hormone therapy type, in other words, once the cancer has become castrate resistant. Researchers at the Centre Hospitalier de i’Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada evaluated the effect of zoledronic [...]

By Malecare|2017-10-19T10:53:24-04:00December 15th, 2010|Advanced Prostate Cancer, bisphosphonates, Drugs & Treatments, General Information, Metastases, Uncategorized, Understanding APC, Zometa|2 Comments

Denosumab delays the Spread of Prostate Cancer to the Bones, But it Doesn’t Extend Life!

Results from a recent clinical trial indicate that denosumab delayed the spread of prostate cancer metastases bones, however it did not prolong the lives of men. […]

By Malecare|2017-10-19T10:53:24-04:00December 14th, 2010|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, denosumab - Prolia, Drugs & Treatments, General Information, Metastases, Uncategorized, Understanding APC|0 Comments

Capesaris™ (GTx-758) Phase II Proof of Concept Trial – A New On the Horizon Drug To Watch

GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial treating men with advanced prostate cancer, at the Annual Meeting of the Society of Urologic Oncology. Capesaris is a novel oral selective estrogen receptor alpha agonist which GTx is developing for first line treatment of advanced prostate cancer. [...]

By Malecare|2010-12-13T16:51:48-05:00December 13th, 2010|2nd line hormone therapy, Advanced Prostate Cancer, Capesaris, Clinical Trials, Clinical Trials, On The Horizon, Uncategorized, Understanding APC|0 Comments

A Little Humor – Calmness In Our Lives

Recommended For Prostate Cancer Survivors I am passing this on to you because it definitely works, and we could all use a little more calmness in our lives. By following simple advice heard on the Dr. Phil show, you too can find inner peace. Dr Phil proclaimed, “The way to achieve inner peace is to [...]

By Malecare|2010-12-11T21:34:55-05:00December 11th, 2010|Advanced Prostate Cancer, Humor, Uncategorized|0 Comments

Malecare

About Malecare